{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:23Z","timestamp":1761100523161},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,3,1]]},"DOI":"10.1038\/sj.bmt.1702826","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:50:16Z","timestamp":1031154616000},"page":"511-515","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)"],"prefix":"10.1038","volume":"27","author":[{"given":"B","family":"Bj\u00f6rkstrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Apperley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Boogaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Alegre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Remes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JJ","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Blad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Lenhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Iriondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Volin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Littlewood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AH","family":"Goldstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"San Miguel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Gahrton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,4,20]]},"reference":[{"key":"BF1702826_CR1","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","volume":"88","author":"B Bj\u00f6rkstrand","year":"1996","unstructured":"Bj\u00f6rkstrand B, Ljungman P, Svensson H et al. Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma \u2013 a retrospective case-matched study from the European Group for Blood and Marrow Transplantation Blood 1996 88: 4711\u20134718","journal-title":"Blood"},{"key":"BF1702826_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med 1996 335: 91\u201397","journal-title":"N Engl J Med"},{"key":"BF1702826_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(79)90770-0","volume":"1","author":"H Mellstedt","year":"1979","unstructured":"Mellstedt H, Aahre A, Bj\u00f6rkholm M et al. Interferon therapy in myelomatosis Lancet 1979 1: 245\u2013247","journal-title":"Lancet"},{"key":"BF1702826_CR4","first-page":"203","volume":"75","author":"F Mandelli","year":"1990","unstructured":"Mandelli F, Rees JKH, Gorin NC, Prentice HG . Post-remission treatment in acute myeloid leukemia: chemotherapy or autologous or allogeneic bone marrow transplantation Haematologica 1990 75: 203\u2013211","journal-title":"Haematologica"},{"key":"BF1702826_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1200\/JCO.1993.11.1.155","volume":"11","author":"MR Cooper","year":"1993","unstructured":"Cooper MR, Dear K, McIntyre R et al. A randomized clinical trial comparing melphalan\/prednisolone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study J Clin Oncol 1993 11: 155\u2013160","journal-title":"J Clin Oncol"},{"key":"BF1702826_CR6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V81.6.1428.1428","volume":"81","author":"A \u00d6sterborg","year":"1993","unstructured":"\u00d6sterborg A, Bj\u00f6rkholm M, Bj\u00f6reman M et al. Natural interferon-\u03b1 in combination with melphalan\/prednisone versus melphalan\/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden Blood 1993 81: 1428\u20131434","journal-title":"Blood"},{"key":"BF1702826_CR7","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1200\/JCO.1994.12.11.2405","volume":"12","author":"SE Salmon","year":"1994","unstructured":"Salmon SE, Crowley JJ, Grogan TM et al. Combination chemotherapy, glucocorticoids and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study J Clin Oncol 1994 12: 2405\u20132414","journal-title":"J Clin Oncol"},{"key":"BF1702826_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/oxfordjournals.annonc.a059217","volume":"6","author":"H Ludwig","year":"1995","unstructured":"Ludwig H, Cohen AM, Polliack A et al. Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicentre randomized trials and summary of other studies Ann Oncol 1995 6: 467\u2013476","journal-title":"Ann Oncol"},{"key":"BF1702826_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7326\/0003-4819-124-2-199601150-00004","volume":"124","author":"M Hjorth","year":"1996","unstructured":"Hjorth M, Westin J, Dahl IMS et al. Interferon-\u03b12b added to melphalan-prednisolone for initial and maintenance therapy in multiple myeloma: a randomized, controlled trial Ann Intern Med 1996 124: 212\u2013222","journal-title":"Ann Intern Med"},{"key":"BF1702826_CR10","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.leu.2401039","volume":"12","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, San Miguel JF, Escudero ML et al. Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology) Leukemia 1998 12: 1144\u20131148","journal-title":"Leukemia"},{"key":"BF1702826_CR11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bmt.1701403","volume":"22","author":"JL Byrne","year":"1998","unstructured":"Byrne JL, Carter GI, Bienz N et al. Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma Bone Marrow Transplant 1998 22: 639\u2013644","journal-title":"Bone Marrow Transplant"},{"key":"BF1702826_CR12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V79.5.1130.1130","volume":"79","author":"M Attal","year":"1992","unstructured":"Attal M, Huguet F, Schlaifer D et al. Intensive combined therapy for previously untreated aggressive myeloma Blood 1992 79: 1130\u20131136","journal-title":"Blood"},{"key":"BF1702826_CR13","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V85.11.3077.bloodjournal85113077","volume":"85","author":"J-L Harousseau","year":"1995","unstructured":"Harousseau J-L, Attal M, Divine M et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French registry on autologous transplantation in multiple myeloma Blood 1995 85: 3077\u20133085","journal-title":"Blood"},{"key":"BF1702826_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1701062","volume":"21","author":"A Alegre","year":"1998","unstructured":"Alegre A, D\u00edaz-Mediavilla J, San-Miguel J et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish registry Bone Marrow Transplant 1998 21: 133\u2013140","journal-title":"Bone Marrow Transplant"},{"key":"BF1702826_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2141.1998.00795.x","volume":"102","author":"D Cunningham","year":"1998","unstructured":"Cunningham D, Powles R, Malpas J et al. A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results Br J Haematol 1998 102: 495\u2013502","journal-title":"Br J Haematol"},{"key":"BF1702826_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJM199005173222005","volume":"322","author":"F Mandelli","year":"1990","unstructured":"Mandelli F, Avvisati G, Amadori S et al. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy N Engl J Med 1990 322: 1430\u20131434","journal-title":"N Engl J Med"},{"key":"BF1702826_CR17","first-page":"408","volume":"13","author":"GE Browman","year":"1994","unstructured":"Browman GE, Rubin S, Walker L et al. Interferon \u03b1-2b (IFN) maintenance therapy prolongs progression free and overall survival in plasma cell myeloma (PCM) Proc Am Soc Clin Oncol 1994 13: 408","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702826_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.1995.tb08364.x","volume":"89","author":"J Westin","year":"1995","unstructured":"Westin J, R\u00f6djer S, Turesson I et al. Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study Br J Haematol 1995 89: 561\u2013568","journal-title":"Br J Haematol"},{"key":"BF1702826_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0959-8049(94)00452-B","volume":"31","author":"D Peest","year":"1995","unstructured":"Peest D, Deicher H, Coldwey R et al. A comparison of polychemotherapy and melphalan prednisolone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma: a prospective trial of the German Myeloma Treatment Group Eur J Cancer 1995 31: 146\u2013151","journal-title":"Eur J Cancer"},{"key":"BF1702826_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2141.1998.00648.x","volume":"101","author":"MT Drayson","year":"1998","unstructured":"Drayson MT, Chapman CE, Dunn JA et al. MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma. MRC Working Party on Leukaemia in Adults Br J Haematol 1998 101: 195\u2013202","journal-title":"Br J Haematol"},{"key":"BF1702826_CR21","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1200\/JCO.1997.15.4.1672","volume":"15","author":"H Ludwig","year":"1997","unstructured":"Ludwig H, Fritz E, Neuda J, Durie BG . Patient preferences for interferon alfa in multiple myeloma J Clin Oncol 1997 15: 1672\u20131679","journal-title":"J Clin Oncol"},{"key":"BF1702826_CR22","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1200\/JCO.1998.16.8.2834","volume":"16","author":"B Zee","year":"1998","unstructured":"Zee B, Cole B, Li T et al. Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma J Clin Oncol 1998 16: 2834\u20132839","journal-title":"J Clin Oncol"},{"key":"BF1702826_CR23","first-page":"100","volume-title":"VII International Multiple Myeloma Workshop","author":"F Wisl\u00f8ff","year":"1999","unstructured":"Wisl\u00f8ff F . Quality of life and patients\u2019 perception in interferon treated myeloma patients VII International Multiple Myeloma Workshop Stockholm 1999 100"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702826","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:52:38Z","timestamp":1648075958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["BF1702826"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702826","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]},"assertion":[{"value":"26 May 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}